antibiotic gut microbiome

NIAID Data Ecosystem2026-05-02 收录

药物-肠道微生物组互作

非抗生素药物对菌群的影响

数据链接：

https://www.ncbi.nlm.nih.gov/sra/SRP423394 数据链接链接失效反馈

官方服务：

资源简介：

Examining the Composition of Microbes During Exposure to Non-Antibiotic Pharmaceuticals

创建时间：

2024-08-09

Association of metformin administration with gut microbiome dysbiosis in healthy volunteers

药物-肠道微生物组互作

肠道菌群与药物相互作用

Background Metformin is a widely used first-line drug for treatment of type 2 diabetes. Despite its advantages, metformin has variable therapeutic effects, contraindications, and side effects. Here, f

NIAID Data Ecosystem80

Impact of the PARP inhibitor Olaparib on intestinal microbiome: single and combined treatment with cisplatin in female ICR mice

药物-肠道微生物组互作

抗肿瘤药物肠道菌群影响

This study investigates the effects of olaparib, a PARP inhibitor, and its combined administration with cisplatin on the gut microbiota of female ICR mice. Mice were randomly divided into four groups:

NIAID Data Ecosystem20

Effect of a new drug in EAE disease model of multiple sclerosis on the mice gut microbiome

多发性硬化肠道微生物组

药物-肠道微生物组互作

Multiple sclerosis is associated with destruction of oligodendrocytes, demyelination and impaired remyelination. Disease modifying therapies available act mainly anti-inflammatory, neuroregenerative s

NIAID Data Ecosystem40

Gut microbiome of T2DM patients treated with metformin or empagliflozin

糖尿病药物干预

药物-肠道微生物组互作

In this study, we investigated the changes of physiological indexes, serum metabolites and gut microbiome of T2DM paitents treated with metformin or empagliflozin among 4 monthes.

NIAID Data Ecosystem20

antibiotic gut microbiome

资源简介：

相关数据集